Laila-35 ED
cyproterone acetate
Laila-35 ED is a Prescription medicine
Main Indication
Treatment of signs of androgenisation in women such as severe acne (involving inflammation or nodularity, or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree. Laila-35 ED will also provide effective oral contraception in this patient group. If the hirsutism has only recently appeared, or has lately intensified to a considerable extent, the cause (which might be an androgen producing tumour or an adrenal enzyme defect) must be clarified by differential diagnosis.
Therapeutic Area
Endocrinology
Sponsor:
Aspen Australia
|
Queries:
1300 659 646
Laila-35 ED is available in these strengths:
- Laila-35 ED 2mg/35 mcg Tablets 1x28s Pack
- Laila-35 ED 2mg/35 mcg Tablets 3x28s Pack
